scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1046-2023(02)00062-2 |
P698 | PubMed publication ID | 12095268 |
P50 | author | Peter L Molloy | Q41534437 |
P2093 | author name string | Susan J Clark | |
Thu Ho | |||
Wenjia Qu | |||
Keith Rand | |||
P2860 | cites work | MethyLight: a high-throughput assay to measure DNA methylation | Q24515378 |
High sensitivity mapping of methylated cytosines | Q24630600 | ||
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells | Q28216816 | ||
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer | Q34188991 | ||
COBRA: a sensitive and quantitative DNA methylation assay | Q34630070 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | real-time polymerase chain reaction | Q856198 |
DNA methylation | Q874745 | ||
P304 | page(s) | 114-120 | |
P577 | publication date | 2002-06-01 | |
P1433 | published in | Methods | Q6823859 |
P1476 | title | Conversion-specific detection of DNA methylation using real-time polymerase chain reaction (ConLight-MSP) to avoid false positives | |
P478 | volume | 27 |
Q92877054 | An Internal Control for Evaluating Bisulfite Conversion in the Analysis of Short Stature Homeobox 2 Methylation in Lung Cancer |
Q30918824 | Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry. |
Q54263329 | Analysis of epigenetic modifications of DNA in human cells. |
Q36648767 | Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma |
Q38097524 | Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer |
Q33632125 | Circulating Tumor DNA as Biomarkers for Cancer Detection |
Q39003554 | Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns |
Q38018995 | DNA methylation biomarkers in cancer: progress towards clinical implementation |
Q26996421 | DNA methylation biomarkers: cancer and beyond |
Q35599589 | DNA methylation detection: bisulfite genomic sequencing analysis |
Q36725624 | DNA methylation of GSTP1 as biomarker in diagnosis of prostate cancer |
Q61283947 | DNA methylation: Bisulphite modification and analysis |
Q36414343 | E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines |
Q26778026 | Emerging blood-based biomarkers for detection of gastric cancer |
Q38497589 | Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm |
Q36728257 | HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells |
Q24812484 | Headloop suppression PCR and its application to selective amplification of methylated DNA sequences. |
Q49971220 | Helper-Dependent Chain Reaction (HDCR) for Selective Amplification of Methylated DNA Sequences |
Q34654655 | Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma |
Q59799440 | Identification of rare levels of methylated tumor DNA fragments using an optimized bias based pre-amplification-digital droplet PCR (OBBPA-ddPCR) |
Q37201885 | Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing |
Q39927458 | MethyQESD, a robust and fast method for quantitative methylation analyses in HNPCC diagnostics using formalin-fixed and paraffin-embedded tissue samples |
Q35678056 | Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer |
Q36050701 | Methylation profiling of normal individuals reveals mosaic promoter methylation of cancer-associated genes |
Q97520866 | Modern epigenetics methods in biological research |
Q37533620 | Molecular epigenetics and genetics in neuro-oncology |
Q47744278 | Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas |
Q37702670 | NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population |
Q35790157 | Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis |
Q34168829 | Prognostic prediction of glioblastoma by quantitative assessment of the methylation status of the entire MGMT promoter region |
Q90239943 | Promoter Hypermethylation of Tumor-Suppressor Genes p16INK4a, RASSF1A, TIMP3, and PCQAP/MED15 in Salivary DNA as a Quadruple Biomarker Panel for Early Detection of Oral and Oropharyngeal Cancers |
Q33520069 | Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM |
Q33548990 | Quantitative detection of DNA methylation states in minute amounts of DNA from body fluids |
Q34416570 | Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas |
Q92953171 | SIMON: Simple methods for analyzing DNA methylation by targeted bisulfite next-generation sequencing |
Q24646396 | Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection |
Q58212980 | The influence of DNA degradation in formalin-fixed, paraffin-embedded (FFPE) tissue on locus-specific methylation assessment by MS-HRM |
Q28188233 | The power and the promise of DNA methylation markers |
Search more.